- Report
- November 2024
- 150 Pages
Global
From €4471EUR$4,850USD£3,733GBP
- Report
- October 2025
- 160 Pages
Global
From €2913EUR$3,160USD£2,432GBP
€3642EUR$3,950USD£3,040GBP
- Report
- October 2025
- 160 Pages
Global
From €2913EUR$3,160USD£2,432GBP
€3642EUR$3,950USD£3,040GBP
- Report
- October 2025
- 160 Pages
Global
From €2913EUR$3,160USD£2,432GBP
€3642EUR$3,950USD£3,040GBP
- Report
- November 2023
- 176 Pages
Global
From €4103EUR$4,450USD£3,425GBP
- Report
- October 2024
- 167 Pages
Europe
From €3181EUR$3,450USD£2,655GBP
- Report
- June 2024
- 74 Pages
From €3181EUR$3,450USD£2,655GBP
- Report
- April 2024
- 300 Pages
Global
From €4103EUR$4,450USD£3,425GBP
- Report
- May 2025
- 100 Pages
Global
From €4471EUR$4,850USD£3,733GBP
- Report
- March 2026
- 150 Pages
Germany
From €4471EUR$4,850USD£3,733GBP
- Report
- March 2026
- 150 Pages
India
From €4471EUR$4,850USD£3,733GBP
- Report
- March 2026
- 150 Pages
Canada
From €4471EUR$4,850USD£3,733GBP
- Report
- March 2026
- 150 Pages
China
From €4471EUR$4,850USD£3,733GBP
- Report
- September 2025
- 150 Pages
Global
From €4471EUR$4,850USD£3,733GBP
- Report
- September 2025
- 150 Pages
Global
From €4471EUR$4,850USD£3,733GBP
- Report
- September 2025
- 150 Pages
Global
From €4471EUR$4,850USD£3,733GBP
- Report
- August 2025
- 150 Pages
Global
From €4471EUR$4,850USD£3,733GBP
- Report
- July 2025
- 150 Pages
Global
From €4471EUR$4,850USD£3,733GBP
- Drug Pipelines
- July 2023
- 144 Pages
Global
From €13824EUR$14,995USD£11,542GBP
- Drug Pipelines
- August 2020
- 345 Pages
Global
From €1844EUR$2,000USD£1,539GBP

The Lipoprotein market is a subset of the biotechnology industry that focuses on the development of drugs and treatments related to lipoproteins. Lipoproteins are molecules composed of proteins and lipids that are responsible for transporting cholesterol and other lipids throughout the body. Lipoproteins are essential for maintaining healthy cholesterol levels and are involved in many metabolic processes.
The Lipoprotein market is driven by the increasing prevalence of cardiovascular diseases, such as atherosclerosis, and the need for effective treatments. Additionally, the development of new technologies and the increasing availability of data are driving the growth of the Lipoprotein market.
Some of the major companies in the Lipoprotein market include Amgen, AstraZeneca, Merck, Pfizer, and Sanofi. These companies are involved in the development of drugs and treatments related to lipoproteins, as well as the research and development of new technologies. Show Less Read more